Hye E. Park
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Revisiting human sparganosis: a pathologic review from a single institution.
Journal: Journal of pathology and translational medicine
Published: September 22, 2025
Diagnostic value of cytology in detecting human papillomavirus-independent cervical malignancies: a nation-wide study in Korea.
Journal: Journal of pathology and translational medicine
Published: August 11, 2025
Case report of extranodal NK/T-cell lymphoma mimicking Behcet syndrome.
Journal: Medicine
Published: February 18, 2025
The combination of CDX2 expression status and tumor-infiltrating lymphocyte density as a prognostic factor in adjuvant FOLFOX-treated patients with stage III colorectal cancers.
Journal: Journal of pathology and translational medicine
Published: June 03, 2024
Predictive Biomarkers of Lymph Node Metastasis in Early Gastric Cancer: A Reference of Clinicopathological Characteristics, Protein Expression, Epstein-Barr Virus Status, and Microsatellite Instability.
Journal: Anticancer research
Published: May 14, 2024
Identification of Preeclamptic Placenta in Whole Slide Images Using Artificial Intelligence Placenta Analysis.
Journal: Journal of Korean medical science
Published: March 15, 2024
Concomitant expression patterns of CDX2 and SATB2 as prognostic factors in stage III colorectal cancers.
Journal: Annals of diagnostic pathology
Published: February 16, 2024
Comparison of Breast Fine-Needle Aspiration Cytology and Tissue Sampling for High-Throughput Proteomic Analysis and Cancer Biomarker Detection.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: July 15, 2023
Combinatory statuses of tumor stromal percentage and tumor infiltrating lymphocytes as prognostic factors in stage III colorectal cancers.
Journal: Journal of gastroenterology and hepatology
Published: November 04, 2021
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX.
Journal: Scientific reports
Published: May 06, 2021
Last Updated: 09/26/2026